Cytolethal distending toxin (CDT) is a virulence factor produced by many Gram-negative bacteria, including Haemophilus ducreyi, the causative agent of genital chancroid. CDT is a heterotrimeric toxin consisting of a cell-binding domain (CdtA + CdtC) and a catalytic domain (CdtB) that has DNase activity. After binding to the host plasma membrane, CDT undergoes endocytosis and travels through the endosomes en route to the endoplasmic reticulum (ER). Only CdtB and CdtC arrive in the Golgi before moving to the ER. Only then does CdtB move into the nucleus, causing DNA damage that induces cell-cycle arrest and apoptosis. The previous CDT trafficking model suggested that CdtA remains on the plasma membrane while the CdtB/CdtC heterodimer is transported inside the cell. This model is based on experiments that were unable to detect CdtA inside the host cell. Here, we reexamine this model and demonstrate that CDT is internalized as an intact holotoxin. Furthermore, the acidification of the endosomes induces CdtA release from the CdtB/CdtC heterodimer. Using a cell-based ELISA, we report that CdtA facilitates CDT binding to the plasma membrane and demonstrate that nearly the entire pool of surface-bound toxin is internalized from the plasma membrane within 20 minutes. As determined by Western blot, all of internalized CdtA and most of internalized CdtB and CdtC are rapidly degraded in the lysosomes. CdtA colocalized with EEA-1, an early endosomal marker, before lysosomal degradation and was destabilized by the acidic conditions found in the early endosomes (pH 6.0-6.3). This led to its release from the CDT holotoxin as determined by circular dichroism and surface plasmon resonance. The results in this dissertation demonstrate that CDT is internalized as an intact holotoxin, with the acidic environment of endosomes triggering the separation of CdtA from the CdtB/CdtC heterodimer – the first stage of CDT's novel two-stage disassembly.

The emergence of multidrug-resistant (MDR) strains of bacteria and the lack of a novel class of antibiotics has become a global health concern. Pseudomonas aeruginosa is one common MDR bacteria responsible for nosocomial infections and related mortality worldwide. It has developed resistance against commonly available antibiotics and is in the WHO's priority list of bacteria for which new antibiotics are desperately needed. Currently there is a growing interest in developing metal and non-metal-based nanoparticles to target multidrug-resistant bacteria. The objective of this study is to evaluate the efficacy of a novel nanocomposite of two non-traditional antimicrobials: a metal (Ga-III) and a non-metal (chitosan nanoparticle) against P. aeruginosa. It was hypothesized that Gallium (III) nitrate in combination with hydrothermally-treated chitosan biopolymer, which has been widely studied for wound-healing applications, will exhibit synergistic antibacterial activity due to increased modes of action . The Ga(III) nitrate is an FDA approved drug that is used to lower blood levels of calcium in some cancer patients. The drug has been under clinical trials as an antimicrobial agent due to its Iron(III) mimicking property. The chitosan-gallium nanocomposite was synthesized using hydrothermal treatment in acidic conditions. Particle size, surface charge, optical properties, and chemical interactions between Ga (III) and chitosan were studied using Dynamic Light Scattering (DLS), FT-IR, UV-VIS and Fluorescence techniques. Microplate Alamar Blue Assay, Colony Forming Unit assay and Crystal Violet biofilm inhibition assay were conducted to study the antibacterial and antibiofilm properties of the nanocomposite in aqueous suspension (pH 5.7). UV-Visible and fluorescence spectra suggested the formation of optically-active chitosan-gallium nanocomposite, exhibiting broad absorption band (~290-325 nm) and emission at 422 nm. FTIR study confirmed the depolymerization of chitosan and gallium complexation through primary amine groups of chitosan. DLS analysis showed that primary particles have hydrodynamic diameter of 141 nm and average zeta potential of +46 mV at pH 5.7. Microplate alamar blue assay revealed the MIC of the composite to be 32 µg/ml while CFU assay determined the MBC to be 128 µg/ml against P.aeruginosa. Compared to the controls chitosan and gallium nitrate, the chitosan-gallium nanocomposite showed enhanced antibacterial efficacy. Furthermore, there was 21.5% inhibition of biofilm formation at 8 µg/ml of the composite. These preliminary findings suggest the potential of chitosan-gallium nanocomposite as an effective antibacterial agent against P.aeruginosa infections.

Cholera is an acute disease that is a global threat to the world and can kill people within a few hours if left untreated. In the last 200 years, seven pandemics occurred, and, in some countries, it remains endemic. The World Health Organization (WHO) declared a global initiative to prevent cholera by 2030. Cholera dynamics are contributed by several environmental factors such as salinity level of water, water temperature, presence of plankton especially zooplankton such as cladocerans, rotifers, copepods, etc. Vibrio cholerae (V. cholerae) bacterium is the main reason behind the cholera disease and the growth of V. cholerae depends on its host in the water reservoir which is the zooplankton because they share a symbiotic relationship. Investigating plankton bloom could be one of the key indicators for predicting cholera outbreaks. Though there are lots of models for cholera transmission dynamics, there are few existing models focused on the environmental impacts of plankton reservoirs. In this work, we have formulated a model of cholera transmission dynamics with the environmental impacts of plankton reservoirs. We have derived the basic reproduction number and discussed various alternative threshold parameters using the next generation matrix approach. Next, we have considered the existence and stability of the disease-free and positive equilibria. Our model analysis could be helpful for scientists to better understand the impact of environmental factors on cholera outbreaks and eventually for a possible prediction of the timing and location of the next cholera outbreak.

The purpose of this thesis was to investigate new possible compounds that can be used to treat orthopedic implant infections caused by bacterial pathogens. Current treatment includes the use of antibiotics and the DAIR procedure, which stands for debridement, antibiotic therapy, irrigation, and retention. However, antibiotics are becoming less effective as a treatment due to bacteria gaining antibiotic resistance. Two bacterial species involved in orthopedic implant infections are P. aeruginosa and S. aureus. This thesis investigated cerium oxide nanoparticles and L. fermentum, a beneficial bacterium, as possible treatments to stop bacterial growth and the formation of biofilm. This was done by using the Kirby-Bauer disk diffusion method with P. aeruginosa and S. aureus. An XTT assay, a viability assay, was also performed on RAW macrophages to determine how these compounds affect human immune cells. Dextran-coated, 50/50, and 70/30 Ce4+/Ce3+ CNP (cerium oxide nanoparticles) at 1, 10, 20, 100, 500, and 800 µg/mL were investigated. These kinds of CNP were investigated to determine which type of CNP and at what concentration was most effective. The results show significant reductions (p-value ≤ 0.05) in infection totals for various treatments, such as 10 µg/mL 50/50 CNP (cerium oxide nanoparticles). This study adds to the field of research in investigating new treatments for orthopedic implant infections.

Globally, tuberculosis, a disease caused by the species of Mycobacterium tuberculosis (Mtb) complex, stands as a leading cause of death from a single infectious agent. Even though antituberculous drugs are available, treatment is challenging due to antibiotic resistance associated with point mutations in the bacterial genome. Resistance to the first-line antibiotics – rifampin and isoniazid – results in multidrug-resistant tuberculosis (MDR) requiring a more complicated treatment regimen. Timely and accurate identification of drug-resistant TB cases can help prescribe the most effective treatment and prevent the spread of infection. This research aims to develop an assay to discern multi-drug resistant forms of tuberculosis using a molecular assay based on split deoxyribozyme hybridization probes. For the probe design, a catalytic core of an RNA-cleaving deoxyribozyme is split into two parts, with each part elongated with a target-recognizing fragment ("arm"). In the presence of a fully complementary nucleic acid target, but not the one containing point mutations, the catalytic core of the deoxyribozyme can be re-formed due to the assembling of the target-probe complex, which recognizes and allows cleavage of a fluorophore- and quencher-labeled signal reporter, thereby ensuring increase in fluorescence in a target-dependent manner. The target-binding arms of the probes were optimized in terms of the signal-to-background ratio and selectivity of target recognition using synthetic targets corresponding to the fragments of the katG and rpoB genes with point-mutation sites implicated in the resistance to isoniazid and rifampin, respectively. The optimized probe sequences were used to interrogate the targets obtained by amplifying the correspondent fragments of the Mtb genes using Linear- After-The-Exponential (LATE) PCR, which allows efficient synthesis of a single-stranded amplicon. The signal triggered by cognate targets can be read using a portable fluorometer, which eliminates the need to use a sophisticated real-time PCR instrument for the assay. The success of the split deoxyribozyme assay can establish an affordable and user-friendly molecular diagnostic assay where a sample can be amplified and analyzed in a single tube.

Aim The aim was to determine the epidemiology of invasive fungal infections at Chris Hani Baragwanath Hospital. The specific objectives were to determine the 1) risk factors, 2) clinical presentation, 3) laboratory abnormalities, 4) organisms and their susceptibilities and 6) outcome in neonates with positive blood or CSF fungal cultures at Chris Hani Baragwanath Hospital. Methods This was a retrospective record review of patients who had positive blood or CSF cultures. Patients were identified by a computerized microbiological surveillance database. The data was collected over a three-year period from January 2002 to December 2004. Patient hospital files were reviewed for clinical signs, full blood count (FBC), C-reactive protein (CRP) and outcomes. Fungal culture results were reviewed for susceptibilities. To identify risk factors a convenient cohort was compared to the patients with fungal sepsis. The data was analysed using a Statistica software package. Results There were 150 patients with fungal sepsis among admissions over this 3 yearperiod giving an incidence of 1.3 per 100 admissions. Thirty-nine records were not found thus 111 patient records were reviewed. The median birthweight was 1280g and the gestational age 30 weeks. The median age of onset was 16 days and 6.3% had early onset fungal sepsis. There were 61 males. Twenty-eight percent of patients were born to HIV positive mothers. Candida parapsilosis was the commonest (56%) organism isolated followed by C. albicans (43%). All the C. albicans isolates and 93% of the C. parapsilosis isolates were susceptible to amphotericin B. Fluconazole susceptibilities were reported as, 96% for C. albicans, and 60% of the C. parapsilosis as being susceptible. Central venous catheters (CVCs) (p=<0.001), the use of TPN (p=<0.001) and third generation cephalosporins were identified as risk factors associated with fungal sepsis. The all-cause mortality and Candida–related mortality were 30% and 23% respectively. The non-survivors had lower platelet counts (p=0.007) than the survivors. Patients with Gram-negative sepsis had lower platelet counts than the fungal group (p=<0.001) on the repeat laboratory parameters. Conclusion The incidence is 1.3 per 100 admissions. Risk factors associated with fungal sepsis are very low birthweight and gestational age, the use of TPN, CVCs and third generation cephalosporins. Candida parapsilosis is the common organism causing fungal sepsis in neonates. Candida albicans was associated with a higher mortality. Thrombocytopenia is not organism specific to fungal sepsis.

Thèse d'exercice : Médecine. Médecine interne : Nantes : 2007. / Bibliogr.

Reproduction de : Thèse d'exercice : Pharmacie : Nantes : 2009. / Bibliogr.

Thesis (M. Med. Sc.)--University of Hong Kong, 2001. / Includes bibliographical references (leaves 33-36).

Mycoses refer to infections caused by different fungal infections. Some mycoses can be defeated by the hosts themselves attributed to the functional immune systems before severe symptoms appear. However, in immune-compromised patients, including those suffering from AIDS or receiving chemotherapies, those mycoses become lethal. They are called opportunistic systemic mycoses. Among them, two types of the most deadly mycoses, especially for AIDS patients in Southeast Asia, are cryptococcsis and penicillosis, caused by Cryptococcus neoformans (C. neoformans) and Penicillium marneffei (P. marneffei), respectively. Both of them have their own virulence factors to enhance their pathogenicities and survival in hosts. Active research to explore these virulence factors in these two funguses is ongoing. Two proteins from these two pathogens were found to be putative novel virulence factors, MP1p from P. marneffei, and CPL1 from C. neoformans. Collaborators have successfully found that MP1p strongly bound arachidonic acids (AA), the sole precursor of paracrine signaling molecules essential to the onset of inflammatory responses, by various functional studies. This led to the hypothesis that MP1p might be able to suppress inflammatory responses and subsequent immune responses via removal of AA from macrophages engulfed P. marneffei. In this work, X-ray crystal structures of MP1p’s ligand-binding domain 2 (LBD2) from P. marneffei (strain MP1) overexpressed in E. coli, in complex with one and two AA molecules, were successfully solved by molecular replacement method. The resolutions were up to 1.45 Å and 1.50 Å respectively. These structures revealed detailed interactions between MP1p-LBD2 and AA.A possible ligands-dependent dimer-monomer transition in LBD2 was also revealed by both analytical size exclusion chromatography and crystallography. Full length CPL1 overexpressed in yeast was also successfully purified and crystallized. A 3.0 Å native dataset was collected. Heavy atoms derivatives of the crystals would be produced in order to solve the structure via experimental phasing methods. The structural determination of these virulence factors may provide molecular bases at atomic resolution for the developments of drugs targeting MP1p and CPL1 by structure-based drug design to treat, particularly, penicillosis and cryptococcsis in immune-compromised patients. / published_or_final_version / Physiology / Master / Master of Philosophy